World thyroidology news (#2 2015)
https://doi.org/10.14341/ket2015238-44
Abstract
The article contains abstracts of actual modern international researches dedicated to management of various thyroid pathology and influence of accompanying states
About the Authors
Yu A Manuylova
First Moscow State Medical University, Moscow, Russian Federation
M A Sviridonova
Endocrinology Research Centre, Moscow, Russian Federation
References
1. Salvi M, Vannucchi G, Currò N, et al. Efficacy of B-cell targeted therapy with Rituximab in patients with active moderate to severe Graves’ orbitopathy: A randomized controlled study. J Clin Endocrinol Metab. 2015;100(2):422-431. doi: 10.1210/jc.2014-3014.
2. Stan MN, Garrity JA, Carranza Leon BG, et al. Randomized con- trolled trial of Rituximab in patients with Graves’ orbitopathy. J Clin Endocrinol Metab. 2015;100(2):432-441. doi: 10.1210/jc.2014-2572.
3. Liu X, Qiang W, Liu X, et al. A 6-year follow-up of a randomized prospective trial comparing methimazole treatment with or without exogenous L-thyroxine in chinese patients with Graves’ disease. Exp Clin Endocrinol Diabetes. 2014;122(10):564-567. doi: 10.1055/s-0034-1377045.
4. Besancon A, Beltrand J, Le Gac I, et al. Management of neonates born to women with Graves’ disease: a cohort study. Eur J Endocrinol. 2014;170(6):855-862. doi: 10.1530/eje-13-0994.
5. Ma L, Qi H, Chai X, et al. The effects of screening and intervention of subclinical hypothyroidism on pregnancy outcomes: a prospec- tive multicenter single-blind, randomized, controlled study of thy- roid function screening test during pregnancy. J Matern Fetal Neonatal Med. 2015:1-4. doi: 10.3109/14767058.2015.1049150.
6. Kornelius E, Chiou J-Y, Yang Y-S, et al. Iodinated contrast media increased the risk of thyroid dysfunction: A 6-year retrospective cohort study. J Clin Endocrinol Metab. 2015:JC.2015-2329. doi: 10.1210/jc.2015-2329.
7. Busnelli A, Vannucchi G, Paffoni A, et al. Levothyroxine dose adjustment in hypothyroid women achieving pregnancy through IVF. Eur J Endocrinol. 2015:EJE-15-0151. doi: 10.1530/eje-15- 0151.
8. Eugenin EA, Andersen MN, Olsen A-MS, et al. Levothyroxine substitution in patients with subclinical hypothyroidism and the risk of myocardial infarction and mortality. PLoS ONE. 2015; 10(6):e0129793. doi: 10.1371/journal.pone.0129793.
9. Sung T-Y, Lee Y-m, Yoon JH, et al. Long-term effect of surgery in Graves’ disease: 20 years experience in a single institution. Int J Endocrinol. 2015;2015:1-6. doi: 10.1155/2015/542641.
10. Manavela M, Vigovich C, Danilowicz K, et al. Thyroid autoim- mune disorders in patients with acromegaly. Pituitary. 2015. doi: 10.1007/s11102-015-0670-5.
11. Nakamura H, Hirokawa M, Ota H, et al. Is an increase in thyroid nodule volume a risk factor for malignancy? Thyroid. 2015;25(7):804-811. doi: 10.1089/thy.2014.0567.
12. Lo JC, Rivkees SA, Chandra M, et al. Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system. Thyroid. 2015;25(6):698-705. doi: 10.1089/thy.2014.0434.
13. Zamora-Ros R, Rinaldi S, Tsilidis KK, et al. Energy and macronu- trient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer. 2015:n/a-n/a. doi: 10.1002/ijc.29693.
14. Kelderman-Bolk N, Visser TJ, Tijssen JGp, Berghout A. Quality of life in patients with primary hypothyroidism is related to BMI. Eur J Endocrinol. 2015:EJE-15-0395. doi: 10.1530/eje-15-0395.
15. Martin S, Sirbu A, Betivoiu M, et al. IGF1 deficiency in newly diagnosed Graves’ disease patients. Hormones. 2015. doi: 10.14310/horm.2002.1577.
Review
For citations:
Manuylova Yu.A., Sviridonova M.A. World thyroidology news (#2 2015). Clinical and experimental thyroidology. 2015;11(2):38-44. (In Russ.) https://doi.org/10.14341/ket2015238-44
Views:
461
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
